Company / AR per Share
Cytek Biosciences, Inc. AR per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest AR per Share
$0.49
FY2025
5-year range
$0.37 / $0.95
FY2021-FY2025
Trend
+3.7%
vs FY2024
Sector context
#121 of 136
Health Care
What the data says
Cytek Biosciences, Inc.'s ar per share of $0.49 is lower than 89% of companies in the Health Care sector (FY2025). AR per Share has increased for 3 consecutive years, from $0.37 in FY2022 to $0.49 in FY2025.
Based on SEC 10-K filings.
0.49 in FY2025 with a 5-year CAGR of -1.4%.
Improved from $0.43 to $0.49 over the past 2 years.
Health Care sector context is included.
AR per Share over time
Growth rates
- 3-Year CAGR
- +10.0%
- 5-Year CAGR
- -1.4%
- 10-Year CAGR
- -
Sector benchmark
Bottom 11% in Health CareTop 89% of 136This company $0.49 Sector average $12.05
▼
-96.0% below sector average
Key checks
Key Insights
- Cytek Biosciences, Inc.'s ar per share has grown for 3 consecutive years.
- In FY2025, ar per share increased 3.7% year-over-year.
- Ranks #121 out of 136 companies in the Health Care sector.
- Peak ar per share was recorded in FY2021.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | AR per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.49 | +3.7% |
| FY2024 | $0.47 | +9.6% |
| FY2023 | $0.43 | +17.1% |
| FY2022 | $0.37 | -61.6% |
| FY2021 | $0.95 | +82.8% |
| FY2020 | $0.52 | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026